Tag: NSCLC,Non-Small Cell Lung Cancer,Press Releases,blood-based cancer test,cancer diagnostics,lung cancer,molecular diagnostic,oncology,personalized medicine

Biodesix, Inc, announced today that Douglas E. Swan has joined the Company as Vice President, Commercial Operations, reporting directly to David Brunel, Chief Executive Officer. In this newly created position, Mr. Swan will be responsible for all commercial functions related to the marketing and sales of VeriStrat®. VeriStrat represents the company’s first diagnostic test which…